Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-453-4 | CAS number: 107-02-8
PBT assessment
Administrative data
PBT assessment: overall result
- PBT status:
- the substance is not PBT / vPvB
- Justification:
Persistence:
According to the available information on biodegradation in water and sediment, acrolein will be completely mineralized within 3 weeks. Therefore, acrolein is not regarded as persistent. In addition, neither marketed acrolein nor raw acrolein contains one or more constituents with persistence properties or will generate transformation/degradation products with the respective properties.
Bioaccumulation:
The experimental BCF of acrolein was 344 and therefore well below 2000, the thereshold value according to Annex XIII of the REACH regulation. Thus, acrolein is readily biodegradable and the bioaccumulation potential is expected to be low. In addition, neither marketed acrolein nor raw acrolein contains one or more constituents with bioaccumulative properties or will generate transformation/degradation products with the respective properties.
Toxicity:
Acrolein does not fulfil the toxicity criterion (T) laid down in Annex XIII of the REACH regulation:
• the long-term no-observed effect concentration (NOEC) for marine or freshwater organisms is not lower than 0.01 mg/l
• substance is not classified as carcinogenic (category 1A or 1B), germ cell mutagenic (category 1A or 1B), or toxic for reproduction (category 1A, 1B or 2), and
• there is no other evidence of chronic toxicity, as identified by the classifications: STOT (repeated exposure), category 1 (oral, dermal, inhalation of gases/vapours, inhalation of dust/mist/fume) or category 2 (oral, dermal, inhalation of gases/vapours, inhalation of dust/mist/fume)according to the CLP Regulation.
In addition, neither marketed acrolein nor raw acrolein contains one or more constituents which fulfil the toxicity criterion or will generate transformation/degradation products with the respective properties.
Summary and overall Conclusions on PBT or vPvB Properties
Acrolein does not meet the PBT or vP/vB criteria according to Annex XIII of the REACH regulation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
